Author response to Cunha et al.
Saved in:
| Title: | Author response to Cunha et al. |
|---|---|
| Authors: | Colen RR; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA anaing@mdanderson.org colenrr@upmc.edu.; Department of Radiology, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Rolfo C; Center for Thoracic Oncology at Tisch Cancer Institute, Mount Sinai Health System & Icahn School of Medicine at Mount Sinai, New York, New York, USA., Ak M; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Radiology, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Ayoub M; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Department of Radiology, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Ahmed S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Elshafeey N; Department of Breast Imaging, Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mamindla P; Department of Radiology, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Zinn PO; Department of Neurosurgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Ng C; Abdominal Imaging Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vikram R; Abdominal Imaging Department, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bakas S; Department of Radiology, Pathology, and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Peterson CB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rodon Ahnert J; Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Subbiah V; Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Karp DD; Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Stephen B; Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hajjar J; William T Shearer Center for Human Immunobiology, Texas Children's Hospital, Houston, Texas, USA.; Section of Immunology, Allergy and Retrovirology, Baylor College of Medicine, Houston, Texas, USA., Naing A; Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA anaing@mdanderson.org colenrr@upmc.edu. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jul; Vol. 9 (7). |
| Publication Type: | Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
